Polyurethane-Coated Implants Significantly Cut Complications for Breast Cancer Patients After Mastectomy

Groundbreaking Research Points to Safer Implant Option for Breast Cancer Survivors

Women undergoing breast reconstruction following a mastectomy face significantly fewer complications when they receive polyurethane-coated implants rather than standard silicone ones, according to compelling new research presented at the European Breast Cancer Conference in Barcelona.

The findings offer a critical step forward in personalised breast cancer care — particularly for the tens of thousands of women each year who must navigate both cancer treatment and reconstructive surgery.

The Scale of the Problem

Breast cancer affects approximately 55,000 women in the United Kingdom annually. Roughly 30% of those diagnosed undergo a mastectomy, and a substantial proportion of that group will go on to require radiotherapy as part of their overall treatment plan.

While many women choose breast reconstruction to restore their body image and confidence, the combination of implants and radiotherapy has long been associated with a painful and frustrating complication: capsular contracture. This condition occurs when hard, dense scar tissue forms around the implant, causing discomfort and often requiring additional surgical intervention.

Despite its prevalence, there has historically been very little real-world clinical data examining whether the specific type of implant used could meaningfully reduce this risk — until now.

What the Study Involved

European researchers tracked approximately 1,500 women across 15 countries who were treated for breast cancer between 2016 and 2024. All participants had undergone a mastectomy followed by implant-based breast reconstruction and subsequent radiotherapy.

Around one-third of the women received polyurethane-coated implants — silicone implants encased in a soft, spongy polyurethane outer layer — while just under 1,000 women received conventional, non-coated silicone implants. Researchers then monitored health outcomes over a follow-up period of two-and-a-half to three years.

Key Findings: A Striking Difference in Outcomes

The preliminary results were striking. Women who received polyurethane-coated implants were far less likely to develop capsular contracture compared to those with standard implants.

• 32.8% of women with polyurethane-coated implants developed capsular contracture
• 47.5% of women with standard silicone implants experienced the same complication

Beyond scarring, those with polyurethane-coated implants were also less likely to require secondary surgery to remove scar tissue and had lower rates of serious breast infections.

Expert Insight

Dr. Kerstin Wimmer, a surgeon at the Medical University of Vienna, highlighted the significance of these results: "Our study suggests that women who received polyurethane-coated implants had far fewer problems after radiotherapy than those who received standard implants."

She added that the type of implant selected may have a major bearing on a patient's risk of post-radiotherapy complications, and that these findings should actively inform reconstructive planning for women likely to need radiation treatment.

Professor Isabel Rubio, Head of Breast Surgical Oncology at the Clínica Universidad de Navarra in Madrid, emphasised the broader implications for patient wellbeing: "As we continue to move towards more personalised breast cancer care, evidence like this is valuable in guiding implant selection and treatment planning. The ultimate goal is not only to treat the cancer effectively, but also to minimise long-term side effects and enhance recovery for patients."

What This Means for Patients

Clinical experts in the UK have also welcomed the research. Catherine Priestley, Senior Clinical Nurse Specialist at Breast Cancer Now, stressed the importance of understanding how different implants interact with radiotherapy:

"It can help women make more informed and personalised choices, helping them to live better following breast cancer treatment. We know how emotionally and physically difficult it is for women to go through further procedures when they are already adjusting to breast cancer treatment or changes to their body after surgery."

Sarah Downey, President of the Association of Breast Surgery, echoed this sentiment, affirming that breast implants remain a vital reconstructive option that can restore confidence and quality of life, while calling for continued research in this evolving field.

A Step Toward More Personalised Breast Cancer Care

This study represents an important milestone in efforts to tailor breast cancer treatment to individual patient needs. By demonstrating that implant choice can directly affect complication rates following radiotherapy, researchers have provided clinicians and patients with a powerful tool for shared decision-making.

For the many women facing the dual challenge of cancer recovery and reconstructive surgery, these findings may ultimately mean fewer operations, less pain, and a smoother path to reclaiming their health and confidence.